Gal Wagner-Kolasko's scientific contributions
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (9)
Background:
Transgender men are a marginalized population with unique health care needs. However, their usage of health services is low because of considerable discrimination. A major factor in their avoidance is patient-provider interactions.
Methods:
This cross-sectional study included 102 transgender men who anonymously completed a 55-item qu...
The recent global outbreak of the human monkeypox virus was declared a public health emergency by the WHO. Modified Vaccinia Ankara (MVA), provided in a two-dose regimen, is currently the only FDA-approved vaccine against monkeypox virus infection (MPXVi). Nevertheless, many have implemented a single-dose strategy to maximize vaccine supply because...
Background
The recent global outbreak of the human monkeypox virus (MPXV) was declared a public health emergency by the World Health Organization. Modified Vaccinia Ankara (MVA) is currently the only FDA-approved vaccine against MPXV that was approved for this indication based on a study in non-human primates. Since there is currently scarce eviden...
Background
The recent global outbreak of the human monkeypox virus (MPXV) was declared a public health emergency by the World Health Organization. Modified Vaccinia Ankara (MVA) is currently the only FDA-approved vaccine against MPXV that was approved for this indication based on a study in non-human primates. Since there is currently scarce eviden...
Background
The global supply of vaccines against monkeypox virus infection (MPXVi) is significantly lower than demand. Evidence-based vaccine prioritization criteria, based on risk assessment, are essential for fair vaccine distribution. Our objective was to identify the characteristics of individuals at the highest risk for MPXVi.
Methods
This pop...
Background As the current global resurgence of monkeypox virus infection (MPXVi) continues, the immediate supply of vaccines is lower than the demand. Therefore, prioritization of vaccinations for the highest risk subjects using routine medical records is warranted. Methods This population-based cohort study included all Clalit Health Services (CHS...
Social distancing including lockdowns are acceptable measures to cope with the COVID-19 pandemic. In this cross sectional study, we surveyed the impact of these measurements on sexual behavior and pre-exposure prophylaxis for HIV (PrEP) use among MSM. A digital questionnaire was distributed via social media and geographically based meeting applicat...
Research question
What are the fertility preservation (FP) rates of transgender women and transgender men, and which factors affect their decision making?
Design
This prospective study included 97 transgender women and 91 transgender men referred to the Gender Clinic of our medical center's Endocrinology Institute and to the Gan Meir Community Hea...
Previously, we identified a Chlamydia trachomatis Lymphogranuloma venereum (LGV) recombinant strain possessing a unique non-LGV ompA genotype. Here, culture-independent genome sequencing confirms its circulation in Europe, Middle East and North America, and unveils genetic evidence of emergence of antibiotic resistance. Multi-country and systematic...
Citations
... With regard to occasional partnership, the change in behavior among MSM is in line with previous studies showing a decline in occasional-partner associated with the fear of severe COVID-19 and an increase in online sex practices [11]. Although the large majority of health facilities providing PrEP remained open during the COVID-19 pandemic in Switzerland, PrEPinterruptions or fewer opportunities for STD testing during the COVID-19 lockdown might have contributed to a decrease in sex with occasional-partner [12]. ...
... One study reported that 67.4% of transgender women and 61.6% of transgender men had a desire to parent a child, with 50% and 37%, respectively, desiring a biological one. 8 Thus, fertility counseling early in the transition process can aid in attaining these goals. Health care providers should be sure to discuss all options with patients prior to hormone therapy or surgical intervention. ...
... In Portugal, MSM also dominate the number of increasing LGV cases with approximately 11% of all C. trachomatis-positive samples being positive also for LGV [15,34]. L2 and L2 subvariants dominate the LGV endemic in Europe, but new hybrid variants have been identified as already established global spread [15,[34][35][36][37]. In the United States (USA), LGV was detected in 14% of 132 remnant rectal samples that were positive for C. trachomatis, and all of these LGV-positive samples were among men and resulted as genotype L2, consistent with European data [38]. ...